#J&J will resume COVID-19 vaccine rollout in Europe

#J&J will resume COVID-19 vaccine rollout in Europe

“#J&J will resume COVID-19 vaccine rollout in Europe” Johnson & Johnson will resume its COVID-19 vaccine rollout in Europe, the company announced Tuesday, with added packaging labels warning of a rare risk of blood clots. The announcement came after Europe’s health regulator, the European Medicines Agency, said the vaccine’s benefits outweigh the risk of the…

Read More
#US COVID-19 cases, hospitalization, death rates rising

#US COVID-19 cases, hospitalization, death rates rising

“#US COVID-19 cases, hospitalization, death rates rising” Average daily COVID-19 cases, hospital admissions and death rates are on the rise in the US — just as federal officials paused the Johnson & Johnson vaccine. The US recorded a seven-day daily average of 67,530 cases in the past week, up 6 percent from the previous week,…

Read More
#CEO at Johnson & Johnson COVID vaccine company got 51% raise

#CEO at Johnson & Johnson COVID vaccine company got 51% raise

“#CEO at Johnson & Johnson COVID vaccine company got 51% raise” Emergent BioSolutions, the manufacturer at the center of the Johnson & Johnson coronavirus vaccine bungle, gave its chief executive officer a 51 percent compensation bump in 2020 — bringing his total remuneration to a whopping $5.6 million. On top of a lucrative $893,000 salary,…

Read More
#Johnson & Johnson working on vaccines for COVID-19 variants

#Johnson & Johnson working on vaccines for COVID-19 variants

“#Johnson & Johnson working on vaccines for COVID-19 variants” Johnson & Johnson is working to develop modified versions of its COVID-19 vaccine that may be needed to protect against virus variants, a report said. “We’re working on several next generations of vaccines,” J&J Chief Executive Alex Gorsky said Thursday during an online discussion, according to…

Read More